Alaa Atamna

1.2k citations
45 papers · 763 indexed · h-index 14
Topics
Clostridium difficile and Clostridium perfringens research (11 papers)Microscopic Colitis (8 papers)COVID-19 Clinical Research Studies (5 papers)

In The Last Decade

Alaa Atamna

39 papers receiving 748 citations

Peers

Alaa Atamna
Comparison fields: 5 of 100
  • Infectious Diseases 379
  • Epidemiology 296
  • Surgery 146
  • Oncology 74
  • Pulmonary and Respiratory Medicine 59
Replace Su Hwan Lee with:
Su Hwan Lee South Korea
Kensuke Shoji Japan
Sreedhar Adapa United States
Samuel Ajayi Nigeria
George N. Okoli Canada
Vikas Singla India
Susanna Szpunar United States
Elizabeth R. C. Millett United Kingdom
Malin Inghammar Sweden
Emma Kaplan‐Lewis United States
Alaa Atamna relative to Su Hwan Lee South Korea Su Hwan Lee's profile →
Citations per field
00.5×1.5×
Su Hwan Lee · 1×
Citations per year

Countries citing papers authored by Alaa Atamna

Since Specialization
Citations

This map shows the geographic impact of Alaa Atamna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Atamna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Atamna more than expected).

Fields of papers citing papers by Alaa Atamna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Atamna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Atamna. The network helps show where Alaa Atamna may publish in the future.

Co-authorship network of co-authors of Alaa Atamna

This figure shows the co-authorship network connecting the top 25 collaborators of Alaa Atamna. A scholar is included among the top collaborators of Alaa Atamna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaa Atamna. Alaa Atamna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 6
6 1
7 4
8 7
9 3
10 15
11 9
12 146
13 29
14 10
15 3
16 23
17 242
18 34
19 12
20 27

About Alaa Atamna

Alaa Atamna is a scholar working on Infectious Diseases, Epidemiology and Transplantation, having authored 45 papers that have together received 763 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (11 papers), Microscopic Colitis (8 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Infectious Diseases (379 citations), Epidemiology (296 citations) and Transplantation (19 citations). Alaa Atamna has collaborated with scholars based in Israel, Switzerland and United States. Frequent co-authors include Amit Akirov, Hiba Masri‐Iraqi, Ilan Shimon, Jihad Bishara, Dafna Yahav, Haim Ben‐Zvi, Avishay Elis, Benaya Rozen‐Zvi, Ruth Rahamimov and Tomer Avni. Their work appears in journals such as The American Journal of Medicine, European Respiratory Journal and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026